Chemours Financial Statements
NYSE: CCIndustrialsMajor ChemicalsUSD
Market open · Delayed 15 min · as of Oct 9, 1:07 PM ET
Chemours revenue and earnings
In fiscal 2025, Chemours generated $5.81 billion in revenue, up 0.4% from fiscal 2024. Chemours reported a net loss of $386.0 million, compared with net income of $69.0 million a year earlier. Gross margin was 15.5% (down from 19.8%).
Diluted earnings per share came in at -$2.57, down from $0.46. Over the last 5 fiscal years, CC's revenue has grown at a 3.2% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Chemours income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.81B | 5.78B | 6.08B | 6.83B | 6.34B | 4.97B | 5.53B | 6.64B | 6.18B | 5.40B |
| Revenue growth (YoY) | +0.45% | -4.87% | -11.02% | +7.66% | +27.69% | -10.08% | -16.75% | +7.36% | +14.50% | -5.54% |
| Cost of Revenue | 4.91B | 4.64B | 4.78B | 5.21B | 4.96B | 3.90B | 4.46B | 4.67B | 4.44B | 4.30B |
| Gross Profit | 902.00M | 1.14B | 1.30B | 1.62B | 1.38B | 1.07B | 1.06B | 1.97B | 1.75B | 1.10B |
| Operating Expenses | 966.00M | 823.00M | 1.55B | 844.00M | 705.00M | 700.00M | 715.00M | 788.00M | 764.00M | 1.20B |
| Research & Development | 108.00M | 109.00M | 108.00M | 118.00M | 107.00M | 93.00M | 80.00M | 82.00M | 81.00M | 81.00M |
| Selling, General & Admin | 799.00M | 598.00M | 1.29B | 710.00M | 592.00M | 527.00M | 548.00M | 657.00M | 626.00M | 946.00M |
| Interest Expense | 269.00M | 263.00M | 208.00M | 163.00M | 185.00M | 210.00M | 208.00M | 195.00M | 214.00M | 219.00M |
| Other Income (Expense) | 26.00M | 8.00M | 91.00M | 70.00M | 163.00M | 21.00M | -293.00M | 162.00M | 113.00M | 267.00M |
| Pretax Income | -277.00M | 106.00M | -318.00M | 741.00M | 676.00M | 179.00M | -124.00M | 1.16B | 912.00M | -11.00M |
| Income Tax | 109.00M | 37.00M | -66.00M | 163.00M | 68.00M | -40.00M | -72.00M | 159.00M | 165.00M | -18.00M |
| Net Income | -386.00M | 69.00M | -253.00M | 578.00M | 608.00M | 219.00M | -52.00M | 995.00M | 746.00M | 7.00M |
| Net Income growth (YoY) | -659.42% | — | -143.77% | -4.93% | +177.63% | — | -105.23% | +33.38% | +10557.14% | — |
| EPS (Basic) | -2.57 | 0.46 | -1.70 | 3.72 | 3.69 | 1.33 | -0.32 | 5.62 | 4.04 | 0.04 |
| EPS (Diluted) | -2.57 | 0.46 | -1.70 | 3.65 | 3.60 | 1.32 | -0.32 | 5.45 | 3.91 | 0.04 |
| Shares Outstanding (Basic) | 150.24M | 149.49M | 148.91M | 155.36M | 164.94M | 164.68M | 164.82M | 176.97M | 184.84M | 181.62M |
| Shares Outstanding (Diluted) | 150.24M | 150.17M | 148.91M | 158.30M | 168.70M | 166.35M | 164.82M | 182.57M | 190.98M | 183.42M |
| Gross Margin | 15.53% | 19.75% | 21.42% | 23.66% | 21.77% | 21.47% | 19.24% | 29.69% | 28.22% | 20.43% |
| Net Margin | -6.65% | 119.00% | -4.16% | 8.46% | 9.58% | 4.41% | -94.00% | 14.99% | 12.07% | 13.00% |
This table shows 10 annual periods of Chemours's income statement, from FY 2025 back to FY 2016, across 17 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CC's reporting calendar. What is a income statement?